Literature DB >> 19230592

Transport and metabolism of some cationic ubiquinone antioxidants (MitoQn) in Caco-2 cell monolayers.

Yan Li1, J Paul Fawcett, Hu Zhang, Ian G Tucker.   

Abstract

MitoQn are mitochondria-targeted antioxidants with structures linking a triphenyphosphonium cation to an ubiquinone moiety by a linear n-carbon alkyl chain. The antioxidant efficacy of MitoQn has been shown to be optimum when n = 10 but little is known about the relative transport and metabolism of these homologues. The present study examined the absorptive and secretory transport and metabolism of MitoQn (n = 3, 5 and 10) in Caco-2 cell monolayers. During absorptive transport in the apical-to-basolateral (AB) direction, intracellular accumulation was found to be proportional to lipophilicity but permeation (PappAB) was not, being high for MitoQ3 and low for MitoQ5 and MitoQ10. Secretory transport was greater than absorptive transport with efflux ratios (PappBA/PappAB) for n = 3, 5 and 10 of 2.3, 24.9 and 4.0, respectively. In the presence of the P-glycoprotein inhibitor cyclosporine A (CsA) 30 microM, PappAB values for n = 3, 5 and 10 were increased by 12, 195% and 30%, respectively whereas PappBA values were decreased by 81%, 61% and 68% respectively. In the presence of protein (4% bovine serum albumin) on the B side, PappAB of MitoQ10 (log P 3.44) increased 9-fold whereas PappAB of MitoQ5 (log P 1.14) remained unchanged, both with no change in permeability to the paracellular probe, mannitol. During transport, metabolism to the corresponding reduced ubiquinol species and their sulfate and glucuronide conjugates was detected by liquid chromatography tandem mass spectrometry. In conclusion, the permeation of these cationic ubiquinone antioxidants in Caco-2 cell monolayers depends on a balance between lipophilicity, transporter affinity, protein binding and affinity for phase 2 metabolizing enzymes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19230592     DOI: 10.1007/BF03190873

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  26 in total

1.  Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs.

Authors:  Duxin Sun; Hans Lennernas; Lynda S Welage; Jeffery L Barnett; Christopher P Landowski; David Foster; David Fleisher; Kyung-Dall Lee; Gordon L Amidon
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

2.  Enteropathogenic Escherichia coli markedly decreases the resting membrane potential of Caco-2 and HeLa human epithelial cells.

Authors:  M A Stein; D A Mathers; H Yan; K G Baimbridge; B B Finlay
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

3.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.

Authors:  P Artursson; J Karlsson
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

4.  Transport and metabolism of MitoQ10, a mitochondria-targeted antioxidant, in Caco-2 cell monolayers.

Authors:  Yan Li; J Paul Fawcett; Hu Zhang; Ian G Tucker
Journal:  J Pharm Pharmacol       Date:  2007-04       Impact factor: 3.765

5.  Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools.

Authors:  Andrew M James; Helena M Cochemé; Robin A J Smith; Michael P Murphy
Journal:  J Biol Chem       Date:  2005-03-23       Impact factor: 5.157

6.  Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.

Authors:  Matthew D Troutman; Dhiren R Thakker
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

7.  Quantitation and metabolism of mitoquinone, a mitochondria-targeted antioxidant, in rat by liquid chromatography/tandem mass spectrometry.

Authors:  Yan Li; Hu Zhang; J Paul Fawcett; Ian G Tucker
Journal:  Rapid Commun Mass Spectrom       Date:  2007       Impact factor: 2.419

Review 8.  Targeting antioxidants to mitochondria by conjugation to lipophilic cations.

Authors:  Michael P Murphy; Robin A J Smith
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

9.  Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury.

Authors:  Victoria J Adlam; Joanne C Harrison; Carolyn M Porteous; Andrew M James; Robin A J Smith; Michael P Murphy; Ivan A Sammut
Journal:  FASEB J       Date:  2005-07       Impact factor: 5.191

10.  Fine-tuning the hydrophobicity of a mitochondria-targeted antioxidant.

Authors:  Jordi Asin-Cayuela; Abdul-Rahman B Manas; Andrew M James; Robin A J Smith; Michael P Murphy
Journal:  FEBS Lett       Date:  2004-07-30       Impact factor: 4.124

View more
  2 in total

1.  A Novel Triphenylphosphonium Carrier to Target Mitochondria without Uncoupling Oxidative Phosphorylation.

Authors:  Chaitanya A Kulkarni; Brian D Fink; Bettine E Gibbs; Pratik R Chheda; Meng Wu; William I Sivitz; Robert J Kerns
Journal:  J Med Chem       Date:  2021-01-04       Impact factor: 7.446

2.  P-glycoprotein (Mdr1a/1b) and breast cancer resistance protein (Bcrp) decrease the uptake of hydrophobic alkyl triphenylphosphonium cations by the brain.

Authors:  Carolyn M Porteous; David K Menon; Franklin I Aigbirhio; Robin A J Smith; Michael P Murphy
Journal:  Biochim Biophys Acta       Date:  2013-02-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.